Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-29

Clinical Trial Update: The Effect of Vitamin K2 on Bone Turnover [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effect of Vitamin K2 on bone turnover in osteoporosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin K2 (menaquinone)

Snippet

Sponsor: Eisai Limited | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED